Essity AB (publ) (ETTYF)
| Market Cap | 18.42B -10.0% |
| Revenue (ttm) | 14.36B -6.2% |
| Net Income | 1.31B -0.8% |
| EPS | 1.91 +0.9% |
| Shares Out | n/a |
| PE Ratio | 14.05 |
| Forward PE | 12.65 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,700 |
| Average Volume | 815 |
| Open | 26.50 |
| Previous Close | 26.80 |
| Day's Range | 26.50 - 26.50 |
| 52-Week Range | 24.65 - 29.99 |
| Beta | 0.37 |
| RSI | 45.63 |
| Earnings Date | Apr 23, 2026 |
About Essity AB
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, prof... [Read more]
Financial Performance
In 2025, Essity AB's revenue was 138.49 billion, a decrease of -4.85% compared to the previous year's 145.55 billion. Earnings were 12.66 billion, a decrease of -39.41%.
Financial numbers in SEK Financial StatementsNews
Essity AB Transcript: CMD 2026
The event outlined a sharpened strategic focus, including a strategic review of the Consumer Tissue business and a shift toward higher value-added segments. Financial targets include >3% organic growth and >15% margin, supported by cost savings, innovation, and increased investment in high-return areas. Business units detailed clear growth strategies and margin ambitions.
Essity AB (ETTYF) Q1 2026 Earnings Call Highlights: Navigating Currency Challenges and ...
Essity AB (ETTYF) Q1 2026 Earnings Call Highlights: Navigating Currency Challenges and Strategic Growth
Q1 2026 Essity AB (publ) Earnings Call Transcript
Q1 2026 Essity AB (publ) Earnings Call Transcript
Essity AB Earnings Call Transcript: Q1 2026
Organic sales and volume growth, improved margins, and strong cash flow marked Q1 2026, supported by a major North American acquisition and a SEK 3 billion share buyback. Input cost inflation and selective price increases are expected to shape results in H2.
Essity downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Essity (ETTYF) to Underweight from Neutral with a price target of SEK 215, down from SEK 245. The firm says the company is facing pressure from higher pulp
Essity price target lowered to SEK 290 from SEK 315 at UBS
UBS analyst Charles Eden lowered the firm’s price target on Essity (ETTYF) to SEK 290 from SEK 315 and keeps a Buy rating on the shares.
Essity price target lowered to SEK 247 from SEK 252 at Jefferies
Jefferies analyst David Hayes lowered the firm’s price target on Essity (ETTYF) to SEK 247 from SEK 252 and keeps a Hold rating on the shares. The firm estimates the
Essity price target lowered to SEK 225 from SEK 235 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Essity (ETTYF) to SEK 225 from SEK 235 and keeps a Sell rating on the shares.
Invitation to presentation of Essity's interim report for quarter 1, 2026
STOCKHOLM, March 23, 2026 /PRNewswire/ -- The hygiene and health company, Essity, will publish its interim report for quarter 1, 2026 on April 23 at approximately 07:00 CET. President and CEO Ulrika K...
Essity price target lowered to SEK 245 from SEK 260 at JPMorgan
JPMorgan analyst Celine Pannuti lowered the firm’s price target on Essity (ETTYF) to SEK 245 from SEK 260 and keeps a Neutral rating on the shares.
Essity AB Transcript: UBS Global Consumer and Retail Conference
Strong brands and innovation drive growth in high-margin hygiene and health categories, supported by a decentralized structure and targeted acquisitions. Cost-saving programs and digital transformation underpin efficiency, while disciplined capital allocation supports dividends and buybacks.
Essity price target lowered to SEK 252 from SEK 253 at Jefferies
Jefferies lowered the firm’s price target on Essity (ETTYF) to SEK 252 from SEK 253 and keeps a Hold rating on the shares. The firm, which updated estimates following FY25
Edgewell Personal Care completes sale of feminine care business for $340M
Edgewell Personal Care Company (EPC) completed the sale of its feminine care business to Essity (ETTYF) for $340M. Edgewell intends to use the net proceeds from the sale, after taxes
Essity downgraded to Hold from Buy at Pareto
Pareto analyst Alexander Vilval downgraded Essity (ETTYF) to Hold from Buy with a SEK 270 price target
Essity AB Earnings Call Transcript: Q4 2025
Profit margins improved across all business areas in Q4 2025, despite negative organic sales growth due to price reductions. Strategic acquisitions, strong cash flow, and product innovation supported market share gains and a proposed 6% dividend increase.
Essity downgraded to Neutral from Outperform at BNP Paribas
BNP Paribas downgraded Essity (ETTYF) to Neutral from Outperform with a SEK 290 price target The firm believes valuations in the staples group are likely to stay “cheap.” Published first
Essity price target lowered to SEK 253 from SEK 267 at Jefferies
Jefferies lowered the firm’s price target on Essity (ETTYF) to SEK 253 from SEK 267 and keeps a Hold rating on the shares ahead of the company’s Q4 earnings results,
Invitation to presentation of Essity's report for quarter 4 and full year 2025
STOCKHOLM , Dec. 17, 2025 /PRNewswire/ -- The hygiene and health company Essity will publish its report for quarter 4 and full year 2025 on January 22, 2026, at approximately 07:00 CET. President and ...
Essity price target raised to SEK 267 from SEK 265 at Jefferies
Jefferies raised the firm’s price target on Essity (ETTYF) to SEK 267 from SEK 265 and keeps a Hold rating on the shares. The firm updated the company’s model post
Essity AB Transcript: M&A Announcement
The acquisition of established feminine care brands in North America for $340 million expands market presence, adds scale, and is expected to deliver $30 million in cost synergies by year two. Management aims to revitalize the brands through innovation and brand building, targeting long-term growth and margin improvement.
Essity price target raised to SEK 260 from SEK 255 at JPMorgan
JPMorgan raised the firm’s price target on Essity (ETTYF) to SEK 260 from SEK 255 and keeps a Neutral rating on the shares.
Essity AB Earnings Call Transcript: Q3 2025
Organic sales grew 0.9% year-over-year, with record gross margins and profit above SEK 5 billion. A major reorganization and SEK 1 billion cost saving program were announced to accelerate growth, with savings to be reinvested in high-return areas.
Essity: Interim Report Quarter 3, 2025
STOCKHOLM , Oct. 23, 2025 /PRNewswire/ -- Organic growth, higher margin and strong cash flow Quarter 3, 2025 Net sales decreased 4.5% to SEK 34,638m (36,274). Excl. currency translation effects, net s...
Essity price target lowered to SEK 255 from SEK 270 at JPMorgan
JPMorgan lowered the firm’s price target on Essity (ETTYF) to SEK 255 from SEK 270 and keeps a Neutral rating on the shares.
Invitation to presentation of Essity's interim report for quarter 3, 2025
STOCKHOLM , Sept. 23, 2025 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for quarter 3, 2025 on October 23, at approximately 07:00 CET.